✦ LIBER ✦

A Bayesian evaluation of enrolling additional patients at the maximum tolerated dose in Phase I trials

✍ Scribed by Mithat Gönen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical trial to determine maxi

✍ Mohammad H. Pourgholami; Michael Szwajcer; Melvin Chin; Winston Liauw; Jonathan 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 341 KB

A phase I/II dose escalating trial evalu

✍ P. Marcellin; G.K.K. Lau; H. Mommeja-Marin; S. Sacks; D. Sereni; J.P. Bronowicki 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase I clinical trial to evaluate the s

✍ Christopher M. Stephenson, Robert D. Levin… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 242 KB

416 POSTER Phase I trial of ixabepilone

✍ A.R. Tan; T. Mekhail; M.J. Edelman; L.C. Iacono; M. Messina; O.C. Trifan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Phase-I/II study to evaluate dose limiti

✍ T. Lissitchkov; G. Arnaudov; D. Peytchev; Kh. Merkle 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 183 KB

Estimating the Probability of Toxicity a

✍ John O'Quigley 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 810 KB